Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Clinical Challenges

News
University Research Sheds Light on Relapse Factors for Hazelden Betty Ford
01/28/2021
A partnership with students at the University of Minnesota has resulted in a new way for the Hazelden Betty Ford Foundation to gain a better understanding the factors that put patients at greater risk for relapse.
A partnership with students at the University of Minnesota has resulted in a new way for the Hazelden Betty Ford Foundation to gain a better understanding the factors that put patients at greater risk for relapse.
A partnership with students at...
01/28/2021
Addiction Professional
News
Mental Health, Opioid Abuse Among Physicians’ Top Concerns Post-Pandemic
01/26/2021
A survey of physicians in 24 nations that was released on Tuesday morning showed that 86% believe mental health issues and depression, along with an increase in opioid abuse, will be among the top non-COVID-19 public health issues after the...
A survey of physicians in 24 nations that was released on Tuesday morning showed that 86% believe mental health issues and depression, along with an increase in opioid abuse, will be among the top non-COVID-19 public health issues after the...
A survey of physicians in 24...
01/26/2021
Addiction Professional
News
Study: Methamphetamine Use is Soaring
01/08/2021
Methamphetamine use—both on its own and in combination with other substances—is on the rise, according to data from a recent study by specialty laboratory Millennium Health. Results from the study were published in the Journal of Addiction...
Methamphetamine use—both on its own and in combination with other substances—is on the rise, according to data from a recent study by specialty laboratory Millennium Health. Results from the study were published in the Journal of Addiction...
Methamphetamine use—both on its...
01/08/2021
Addiction Professional
News
Spark Receives FDA Clearance for Neurostimulation Device to Treat Opioid Withdrawal
01/07/2021
Spark Biomedical, a Texas-based medical device company, announced this week that the FDA has granted 510(k) clearance for its Sparrow Therapy System, a wearable neurostimulation device for the treatment of opioid withdrawal. With FDA...
Spark Biomedical, a Texas-based medical device company, announced this week that the FDA has granted 510(k) clearance for its Sparrow Therapy System, a wearable neurostimulation device for the treatment of opioid withdrawal. With FDA...
Spark Biomedical, a Texas-based...
01/07/2021
Addiction Professional
Countering the Quieter Crisis: Addressing Staff Burnout and Strain
Countering the Quieter Crisis: Addressing Staff Burnout and Strain
01/04/2021
Long predicted, the next wave of the COVID-19 pandemic has arrived at our doorstep in full force. The United States is shattering daily case records, states are enacting a patchwork of inconsistent lockdown measures, and field hospitals—often...
Long predicted, the next wave of the COVID-19 pandemic has arrived at our doorstep in full force. The United States is shattering daily case records, states are enacting a patchwork of inconsistent lockdown measures, and field hospitals—often...
Long predicted, the next wave of...
01/04/2021
Addiction Professional
News
Majority of Opioid Overdose Deaths Among Youth Involve Multiple Substances
11/25/2020
Opioid overdose deaths involving multiple substances among youth were found to be more common than overdose deaths involving only opioids, per the results of a study published this week by the Grayken Center at Boston Medical...
Opioid overdose deaths involving multiple substances among youth were found to be more common than overdose deaths involving only opioids, per the results of a study published this week by the Grayken Center at Boston Medical...
Opioid overdose deaths involving...
11/25/2020
Addiction Professional
News
Johns Hopkins Medicine, Maryland Hospitals to Collaborate on Crisis Response Initiative
11/24/2020
Johns Hopkins Medicine announced that it is collaborating with 14 other Maryland hospitals on a five-year initiative aimed at reducing the use of emergency departments and police for substance use and mental health crises.
Johns Hopkins Medicine announced that it is collaborating with 14 other Maryland hospitals on a five-year initiative aimed at reducing the use of emergency departments and police for substance use and mental health crises.
Johns Hopkins Medicine announced...
11/24/2020
Addiction Professional
News
Stimulant Summit: Patients Gaining Sobriety Also Grieve Loss
11/22/2020
As those around an individual in recovery from a substance use disorder celebrate that person regaining sobriety, it’s important for loved ones and practitioners alike to recognize that the person is simultaneously experiencing a loss,...
As those around an individual in recovery from a substance use disorder celebrate that person regaining sobriety, it’s important for loved ones and practitioners alike to recognize that the person is simultaneously experiencing a loss,...
As those around an individual in...
11/22/2020
Addiction Professional
News
Stimulant Summit: Providers Must Weather Storm as COVID Complicates Stimulant Surge
11/21/2020
With the lethality, availability and use of stimulants all greatly increasing in the U.S. in recent years and the COVID-19 pandemic complicating the treatment landscape for patients and practitioners alike, it’s critical for providers to...
With the lethality, availability and use of stimulants all greatly increasing in the U.S. in recent years and the COVID-19 pandemic complicating the treatment landscape for patients and practitioners alike, it’s critical for providers to...
With the lethality, availability...
11/21/2020
Addiction Professional
News
Stimulant Summit: Fentanyl Looms, but Stimulants Pose Increasing Threat in Northeast
11/20/2020
Fentanyl remains the No. 1 illicit substance threat in the state of Vermont, but multiple trends point to cocaine and methamphetamine becoming increasingly prevalent within the state, drug intelligence officer James Downes, MS, and public...
Fentanyl remains the No. 1 illicit substance threat in the state of Vermont, but multiple trends point to cocaine and methamphetamine becoming increasingly prevalent within the state, drug intelligence officer James Downes, MS, and public...
Fentanyl remains the No. 1...
11/20/2020
Addiction Professional

Advertisement

Advertisement

Browse Our Other Brands

Psych NP Institute

 

Psych Congress Network

 

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement